BRIEF published on 09/01/2026 at 18:05, 1 month 3 days ago Thierry Paper's departure from BIOSYNEX Strategy Departure Direction BIOSYNEX Thierry Paper
PRESS RELEASE published on 09/01/2026 at 18:00, 1 month 3 days ago BIOSYNEX SA: Départ de Monsieur Thierry Paper Départ de Monsieur Thierry Paper, co-fondateur de BIOSYNEX, de ses fonctions opérationnelles. Larry Abensur remercie Thierry Paper pour sa contribution au développement de la Société Départ BIOSYNEX Larry Abensur Thierry Paper Laboratoire Français
BRIEF published on 08/06/2026 at 18:20, 1 month 29 days ago BIOSYNEX SA victim of a cyberattack Security Data Cyberattack Health BIOSYNEX
BRIEF published on 08/06/2026 at 18:20, 1 month 29 days ago BIOSYNEX SA victime d'une cyberattaque Santé Sécurité Données BIOSYNEX Cyberattaque
PRESS RELEASE published on 08/06/2026 at 18:15, 1 month 29 days ago BIOSYNEX SA: Cyberattaque BIOSYNEX SA annonce avoir été victime d'une cyberattaque, prenant des mesures pour limiter l'impact et renforcer la sécurité. Aucune conséquence sur l'opérationnel. Enquête en cours Enquête Sécurité Cyberattaque BIOSYNEX SA Laboratoire
BRIEF published on 07/22/2026 at 18:05, 2 months 13 days ago Chiffre d'affaires semestriel de BIOSYNEX en baisse Chiffre D'affaires BIOSYNEX Division Pharmacie Division Diagnostic Rééchelonnement De La Dette
BRIEF published on 07/22/2026 at 18:05, 2 months 13 days ago BIOSYNEX's half-year revenue is down Revenue BIOSYNEX Pharmacy Division Diagnostic Division Debt Rescheduling
PRESS RELEASE published on 07/22/2026 at 18:00, 2 months 13 days ago BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2026 : 44,1 M€ - PERSPECTIVES Biosynex SA annonce un chiffre d'affaires de 44,1 M€ au 1er semestre 2026 avec des perspectives de rééchelonnement de dette et nouveaux marchés Chiffre D'affaires Perspectives BIOSYNEX SA 1er Semestre 2026 Rééchelonnement Dette
BRIEF published on 06/11/2026 at 07:05, 3 months 23 days ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 3 months 23 days ago Biosynex finalise la cession de son activité de biologie moléculaire Cession Restructuration BIOSYNEX Biologie Moléculaire Diagnostic Rapide
Published on 10/03/2026 at 02:35, 1 day 21 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 9 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 10 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 10 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 17 hours 30 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 18 hours 20 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 7 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 23 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 2 days 3 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 5 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 5 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 6 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 6 hours ago Aéroports de Paris SA - Calendrier financier 2027
